Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Presentations from the 23rd Congress of EHA 

    EHA 2018 Nicolini

    Does IFN-α improve outcome of CML in the TKI era?
    Dr Franck-Emmanuel Nicolini, Centre Hospitalier Universitaire de Lyon, France 

    • LSC persistence on TKI
    • IFN-α anti-tumorigenic activities
    • IFN-α alone and CML: last clinical data
    • What do we know nowadays about the combination of IFN-α and TKI?
    • IFN-α alone as maintenance therapy?
    • Conclusions

     We are very grateful for the support of Brandcast media to produce these webstreams.